As of November 6, 2026, Neuronetics, Inc. is a publicly traded company (Nasdaq: STIM). The largest holder reporting an active stake on Schedule 13D is Madryn Asset Management, LP, at 30.3%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Founder or officer holdings: Jorey Chernett, a 10% owner (13.92%). Passive holders reporting on Schedule 13G include Parian Ultreia LP (7%), Point72 (5%) (Schedule 13D/A, March 4, 2026).
Is this your company?
About to sign with, pay or invest in Neuronetics, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Neuronetics, Inc. a real, registered company?
- Neuronetics, Inc. files with the SEC under CIK 1227636 (its SEC filings).
- Its shares are listed under the ticker STIM on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Malvern, Pennsylvania, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Neuronetics, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2026-04-06).
- Leadership changes: the latest reported is Nir Naor (Form 8-K filed 2026-08-17). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Chernett Jorey (filed 2026-08-24).
Who are Neuronetics, Inc.'s owners and officers?
Neuronetics, Inc.: incorporated in Delaware; business address in Malvern, Pennsylvania; industry Surgical & Medical Instruments & Apparatus (Schedule 13D/A, 2026-08-24).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-08-24 | Chernett Jorey | 13.92% |
| Schedule 13G, 2026-08-14 | Point72 Asset Management, L.P. | 5% |
| Schedule 13D/A, 2026-08-04 | Chernett Jorey | 15.22% |
| Schedule 13D/A, 2026-05-27 | Chernett Jorey | 15.17% |
| Schedule 13D/A, 2026-04-08 | Chernett Jorey | 14.12% |
| Schedule 13D, 2026-03-31 | Chernett Jorey | 14.12% |
| Schedule 13G/A, 2026-03-18 | Chernett Jorey | 10.85% |
| Schedule 13G, 2026-03-17 | Parian Ultreia LP | 7% |
| Schedule 13D/A, 2026-03-04 | Madryn Asset Management, LP | 30.3% |
| Schedule 13G/A, 2026-02-04 | Chernett Jorey | 9.9% |
| Schedule 13G, 2025-11-24 | Chernett Jorey | 6.4% |
| Schedule 13D/A, 2025-08-12 | Madryn Asset Management, LP | 31.4% |
Questions about who owns Neuronetics, Inc.
Who owns Neuronetics, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Neuronetics, Inc.: Madryn Asset Management, LP (30.3%, Schedule 13D/A, filed 2026-03-04), Chernett Jorey (13.92%, Schedule 13D/A, filed 2026-08-24), Parian Ultreia LP (7%, Schedule 13G, filed 2026-03-17) and Point72 Asset Management, L.P. (5%, Schedule 13G, filed 2026-08-14).
Who are the largest shareholders of Neuronetics, Inc.?
By the share each holder's latest filing reports, the largest holders of Neuronetics, Inc. on this page are Madryn Asset Management, LP (30.3%), Chernett Jorey (13.92%) and Parian Ultreia LP (7%).
When did Madryn Asset Management, LP buy into Neuronetics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Madryn Asset Management, LP on this page is the Schedule 13D/A, filed 2025-08-12, reporting 31.4%; its latest, Schedule 13D/A filed 2026-03-04, reports 30.3%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Neuronetics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Neuronetics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Neuronetics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-17 | Nir Naor | appointed | ||
| Form 8-K, 2026-07-20 | Nir Naor | Chief Financial Officer | appointed |
Which insiders own Neuronetics, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 10,620,988 shares (13.7% of shares outstanding) (Form 4, 2026-11-02).
- Madryn Health Partners II, LP, a 10% owner: 2,269,073 shares (2.9% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-06-17).
- Madryn Health Advisors GP II, LLC, a 10% owner: 2,269,073 shares (2.9% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-06-17).
- Madryn Health Partners II (CAYMAN Master), LP, a 10% owner: 2,269,073 shares (2.9% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-06-17).
- Madryn Select Opportunities, LP, a 10% owner: 2,269,073 shares (2.9% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-06-17).
Shares outstanding: 77,728,311 as of 2026-10-28, from the company's latest SEC cover page.
How much has Neuronetics, Inc. raised?
No fundraising or offering filing from Neuronetics, Inc. is on file with us.
Red flags found
1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2026-04-06).
Keep reading
More on Neuronetics, Inc. and the records around it.
Neuronetics, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Leadership changes Aug 2026
- Layoff notices Apr 2026
Companies that share a holder
- MADRYN ASSET MANAGEMENT, LP also filed stake reports on 1 other company: Venus Concept Inc. (Mar 2026)
- Parian Ultreia LP also filed stake reports on 2 other companies: EXAGEN INC. (May 2026), Airsculpt Technologies, Inc. (Apr 2026)
- Chernett Jorey also filed stake reports on 16 other companies: CVRx, Inc. (Oct 2026), WW INTERNATIONAL, INC. (Aug 2026), KAZIA THERAPEUTICS LTD (Aug 2026)
Related pages
LayoffsLeadership changes5%+ holders
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/neuronetics